Commit To Buy Spyre Therapeutics At $20, Earn 15.7% Annualized Using Options

Investors considering a purchase of Spyre Therapeutics Inc (SYRE) shares, but tentative about paying the going market price of $30.98/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the March 2025 put at the $20 strike, which has a bid at the time of this writing of $2.05..